Is it time for a new leader in membranous nephropathy, or is it just a game of thrones 👑? This week we're discussing OBI vs TAC in the MAJESTRY trial from #ERA26 🏰🐑 #NephSky We welcome back from retirement @jamiekwillows.bsky.social with the summary ✍️ www.nephjc.com/news/2026/06/22-majestyobi

Heir to the Throne? Obinutuzumab in the membranous nephropathy MAJESTY trial — NephJC

This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy

nephjc.com

Early Programs kick off tomorrow at 7 a.m. CST as #KidneyWk begins in Houston! Get ready for a day of immersive, expert-led learning and discussion focused on key topics like Generative AI, transplant care, diabetes management, genetics, and more. A full day of learning awaits.

Perspective by Abhilash Koratala and Amir Kazory: Point-of-Care Ultrasound in Nephrology: Enthusiasm Alone Won’t Suffice; Training Is Key bit.ly/3FStYDW @nephropocus.bsky.social #POCUS

Point-of-Care Ultrasound in Nephrology: Enthusiasm Alone Won’t Suffice; Training Is Key

bit.ly

Advancing #Nephrology Education with #POCUS: Insights from the #KidneyWk 2024 @asnkidney.bsky.social Precourse. #Nephpearls #FOAMed 🔗 sciencedirect.com/science/arti... Glad to have co-authored this with @nephrothaniel.bsky.social

⚡️ The April issue of POCUS Journal, Vol 10 Issue 1, is out now! We invite you to visit our website (pocusjournal.com) to read articles of interest! 📷 pocusjournal.com/current-issue/ #POCUSJournal #POCUS #FOAMed #FOAMus #MedEd #MedTwitter #echofirst #echo #ultrasound

So grateful to the co-chairs @nephropocus.bsky.social & Amy Mosman for inviting me to the #pocus in nephrology early program @nkf-professionals.bsky.social #SCM25! Always a pleasure to serve with these distinguished thought leaders in the ultrasound-enhanced physical examination space!

Missed our #NKF AZ course? Need more? Gear up for a #pocus in nephrology workshop @nkf-professionals.bsky.social w/course creator & director & erstwhile nephrologist, the worlds' most accomplished crit care fellow, @nephropocus.bsky.social! Limited spots remain! nephropocus.com/2025/03/21/p...

POCUS Precourse at the NKF Spring Clinical Meetings 2025

Excited about learning POCUS but not sure where to start? We’ve got you covered! Our POCUS precourse at the NKF Spring Clinical Meetings is happening on April 9, 2025, in Boston. Designed for begin…

nephropocus.com

Nephrology fellow @michaelturk6.bsky.social of @dukekidney.bsky.social lecturing on #pocus of kidney and bladder 8th annual #pocus immersion course at SW nephrology conference @nkf-professionals.bsky.social AZ

Still time left to join our 2-day #pocus program @ SW Nephrology conference in Phoenix 3/20-3/21 @NKFArizona! swnephrologyconference.org $125 discount for trainees! Guaranteed surfeit of hemodynamic assessment! Featuring: @argaiz.bsky.social @asakhuja.bsky.social @michaelturk6.bsky.social

Indications for mineralocorticoid receptor antagonists (MRAs) in the management of cardio-kidney risk from @theisn.org @kdigo.org @renalphysicians.bsky.social @aspcardio.bsky.social #Nephpearls #Cardiorenal #ISNWCN 🇮🇳 #WCN25 🇮🇳 👉🏼 www.theisn.org/initiatives/...

Next up is the HIT session Rajiv Agarwal on the baseline characteristics of the CONFIDENCE trial Simultaneous Finerenone + Empagliflozin in DKD #ISNWCN #NephSky

Still time left to join our 2-day #pocus program @ SW Nephrology conference in Phoenix 3/20-3/21 @NKFArizona! swnephrologyconference.org $125 discount for trainees! Guaranteed surfeit of hemodynamic assessment! Featuring: @argaiz.bsky.social @asakhuja.bsky.social @michaelturk6.bsky.social